BTSA9

pharmaceutical preparations for treatment of convulsion; therapeutic injectable pharmaceuticals for muscles; pharmaceutical preparations for treatment of sarcopenia; pharmaceutical preparations for treatment of cerebral palsy; pharmaceutical preparations for treatment of hyperhidrosis; pharmaceutical preparations for treatment of headache; pharmaceutical preparations for treatment of trembling disorder; pharmaceutical preparations for treatment of neurological disorder; injectable pharmaceuticals for treatment of ligaments; pharmaceutical preparations for treatment of autonomic nervous system disease; pharmaceutical preparations for treatment of wrinkly skin syndrome; analgesics; injectable pharmaceuticals for treatment of tendon; pharmaceutical preparations including Botolinium toxin; pharmaceutical preparations for treatment of smooth muscle disease; pharmaceutical preparations for treating myotony; pharmaceutical preparations for treating sports injuries; pharmaceutical agents affecting sensory organs; pharmaceutical agents affecting peripheral nervous system; adjuvants for medical purposes; drug delivery agents in the form of injectable solutions for medical purposes for intradermal use; pharmaceutical preparations for central nerve treatment; pharmaceutical preparations for chemical disorder treatment; pharmaceutical preparations for diagnosis of imperceptible wrinkles; chemical preparations for pharmaceutical or medical purposes for the treatment of wrinkles; medicines for human purposes for the treatment of wrinkles